OKYO — OKYO Pharma Ltd
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2022-05-17.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-27 | Patil Rajkumar V. Chief Scientific Officer | Open-market purchase | 3.4K | 1.49 | 5.0K |
| 2026-07-27 | Patil Rajkumar V. Chief Scientific Officer | Grant or award | 3.4K | 1.49 | 5.0K |
| 2026-07-22 | Dempsey Robert John CHIEF EXECUTIVE OFFICER | Grant or award | 15.0K | 1.54 | 23.1K |
| 2026-07-22 | Dempsey Robert John CHIEF EXECUTIVE OFFICER | Open-market purchase | 15.0K | 1.54 | 23.1K |
| 2026-07-21 | CERRONE GABRIELE M Director | Open-market purchase | 22.5K | 1.45 | 32.6K |
| 2026-07-21 | CERRONE GABRIELE M Director | Grant or award | 22.5K | 1.45 | 32.6K |
| 2026-07-21 | Mantelli Flavio CHIEF MEDICAL OFFICER | Open-market purchase | 20.0K | 1.40 | 28.0K |
| 2026-07-21 | Mantelli Flavio CHIEF MEDICAL OFFICER | Grant or award | 20.0K | 1.40 | 28.0K |
| 2026-07-21 | BRANCACCIO JOHN P Director | Open-market purchase | 5.0K | 1.48 | 7.4K |
| 2026-07-21 | BRANCACCIO JOHN P Director | Grant or award | 5.0K | 1.48 | 7.4K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Woodline Partners LP | 5.9M | 3.7M |
| Maven Securities LTD | 1.9M | 1.2M |
| Stonepine Capital Management, LLC | 1.4M | 850.0K |
| Balyasny Asset Management L.P. | 941.5K | 584.8K |
| UBS Group AG | 96.2K | 59.8K |
| XTX Topco Ltd | 60.6K | 37.7K |
| Cerity Partners LLC | 20.6K | 12.8K |
| GEODE CAPITAL MANAGEMENT, LLC | 19.5K | 12.1K |
| Dauntless Investment Group, LLC | 6.1K | 3.8K |
| EFG International AG | 1.5K | 923 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about OKYO
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →